Seres Therapeutics, Inc. financial data

Symbol
MCRB on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 207% % 52%
Debt-to-equity 244% %
Return On Equity 13% %
Return On Assets 3.9% % 6872%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9,586,298 shares -95%
Common Stock, Shares, Outstanding 9,556,446 shares 10%
Entity Public Float $71,941,772 USD -17%
Common Stock, Value, Issued $10,000 USD 11%
Weighted Average Number of Shares Outstanding, Basic 8,858,975 shares 14%
Weighted Average Number of Shares Outstanding, Diluted 8,869,742 shares 14%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $351,000 USD
Revenue from Contract with Customer, Excluding Assessed Tax $351,000 USD
Research and Development Expense $49,060,000 USD -24%
General and Administrative Expense $39,156,000 USD -26%
Operating Income (Loss) $93,971,000 USD 23%
Nonoperating Income (Expense) $99,667,000 USD -69%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $5,696,000 USD 4088%
Earnings Per Share, Basic 0.64 USD/shares 0.56%
Earnings Per Share, Diluted 0.64 USD/shares 1.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $45,766,000 USD 49%
Accounts Receivable, after Allowance for Credit Loss, Current $157,000 USD
Assets, Current $49,376,000 USD 28%
Property, Plant and Equipment, Net $7,635,000 USD -34%
Operating Lease, Right-of-Use Asset $72,483,000 USD -10%
Other Assets, Noncurrent $31,000 USD 0%
Assets $138,193,000 USD -1.2%
Accounts Payable, Current $1,682,000 USD -59%
Employee-related Liabilities, Current $2,685,000 USD -65%
Liabilities, Current $19,322,000 USD -53%
Operating Lease, Liability, Noncurrent $72,576,000 USD -13%
Other Liabilities, Noncurrent $2,077,000 USD 13%
Liabilities $93,975,000 USD -25%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $972,403,000 USD 0.58%
Stockholders' Equity Attributable to Parent $44,218,000 USD 221%
Liabilities and Equity $138,193,000 USD -1.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $26,910,000 USD
Net Cash Provided by (Used in) Financing Activities $1,180,000 USD -94%
Common Stock, Shares Authorized 360,000,000 shares 0%
Common Stock, Shares, Issued 9,556,446 shares 10%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $54,434,000 USD 38%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $310,961,000 USD 0.39%
Deferred Tax Assets, Gross $330,783,000 USD -0.02%
Operating Lease, Liability $82,966,000 USD -9.5%
Payments to Acquire Property, Plant, and Equipment $34,000 USD -45%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $136,000 USD 62%
Lessee, Operating Lease, Liability, to be Paid $118,422,000 USD -14%
Property, Plant and Equipment, Gross $64,248,000 USD -0.74%
Operating Lease, Liability, Current $10,390,000 USD 20%
Lessee, Operating Lease, Liability, to be Paid, Year Two $20,582,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $19,983,000 USD 2.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $35,456,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $20,863,000 USD 1.4%
Deferred Tax Assets, Operating Loss Carryforwards $167,203,000 USD 7.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $13,855,000 USD -1.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $20,132,000 USD -3.5%
Operating Lease, Payments $19,442,000 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $4,133,000 USD -24%
Share-based Payment Arrangement, Expense $10,840,000 USD -48%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%